2022
Exports | Imports
$3.36M | $298MWorld Rnk 87 / 208
Flag Rnk 154 / 1017
World Rnk 65 / 225
Flag Rnk 16 / 1175
2022
ECONOMIC COMPLEXITY of Ecuador
-0.96Rnk 102 / 124
2022
PRODUCT COMPLEXITY IN Vaccines, blood, antisera, toxins and cultures
1.47Rnk 46 / 1025

About

Exports In 2022, Ecuador exported $3.36M in Vaccines, blood, antisera, toxins and cultures, making it the 87th largest exporter of Vaccines, blood, antisera, toxins and cultures in the world. At the same year, Vaccines, blood, antisera, toxins and cultures was the 154th most exported product in Ecuador. The main destination of Vaccines, blood, antisera, toxins and cultures exports from Ecuador are: Chile ($1.63M), Peru ($839k), Colombia ($498k), Costa Rica ($144k), and United States ($61.3k).

The fastest growing export markets for Vaccines, blood, antisera, toxins and cultures of Ecuador between 2021 and 2022 were Chile ($1.63M), Peru ($456k), and Colombia ($254k).

Imports In 2022, Ecuador imported $298M in Vaccines, blood, antisera, toxins and cultures, becoming the 65th largest importer of Vaccines, blood, antisera, toxins and cultures in the world. At the same year, Vaccines, blood, antisera, toxins and cultures was the 16th most imported product in Ecuador. Ecuador imports Vaccines, blood, antisera, toxins and cultures primarily from: United States ($54.5M), China ($32.4M), Switzerland ($26.7M), South Korea ($25.4M), and Belgium ($24.6M).

The fastest growing import markets in Vaccines, blood, antisera, toxins and cultures for Ecuador between 2021 and 2022 were Peru ($17.3M), Germany ($11.9M), and Switzerland ($5.35M).

COMPANIES In 2021, leading companies such as were at the forefront of shipping Vaccines, blood, antisera, toxins and cultures from Ecuador to the United States.

Latest Trends

December 2021

Subnational Monthly Trade

Time Scale
Flow
Color
EXPORT GROWTH (December 2020 - December 2021)$-153k(-99.6%)
IMPORT GROWTH (December 2020 - December 2021)$34.6M(238%)
MAIN DESTINATION (December 2021)Rest of the world$557

This section shows Vaccines, blood, antisera, toxins and cultures's exports and imports data at subnational level for Ecuador. Click any date in the line plot, any subnational region in the geomap, or any destination or origin country to explore the exports or imports behavior of Vaccines, blood, antisera, toxins and cultures over time.

For full datasets download visit Bulk Download page.

Go to Bulk Download

Subscribe today to OEC pro and access the latest data

Sign Up

Subscribe today to OEC pro and access the latest data

Sign Up

Subscribe today to OEC pro and access the latest data

Sign Up

Historical Data

Trade Balance

Color
EXPORTS (2022)$3.36M
IMPORTS (2022)$298M
NET TRADE (2022)-$294M

In 2022, Ecuador exported $3.36M in Vaccines, blood, antisera, toxins and cultures. The main destinations of Ecuador exports on Vaccines, blood, antisera, toxins and cultures were Chile ($1.63M), Peru ($839k), Colombia ($498k), Costa Rica ($144k), and United States ($61.3k).

In 2022, Ecuador imported $298M in Vaccines, blood, antisera, toxins and cultures, mainly from United States ($54.5M), China ($32.4M), Switzerland ($26.7M), South Korea ($25.4M), and Belgium ($24.6M).

Explore Visualizations

Export Destinations (2022)

Import Origins (2022)

Market Growth

Flow
THE FASTEST GROWING Vaccines, blood, antisera, toxins and cultures EXPORT MARKETS FOR Ecuador WERE (2021 - 2022):
Chile$1.63M (2.09M%)
Peru$456k (119%)
Colombia$254k (104%)
THE FASTEST DECLINING MARKETS FOR THE EXPORT OF Vaccines, blood, antisera, toxins and cultures BY Ecuador WERE (2021 - 2022):
Costa Rica-$243k (-62.9%)
South Africa-$55.2k (-100%)
Bolivia-$50.4k (-50%)

Change in Exports by Market (2021 - 2022)

Market Concentration

View
Flow
Type
In 2022, Ecuador's main exporting competitors in Vaccines, blood, antisera, toxins and cultures were:
In 2022, Ecuador's main importing competitors in Vaccines, blood, antisera, toxins and cultures were:

Explore Visualizations

Trade Value of Vaccines, blood, antisera, toxins and cultures by Exporters

Have questions, comments, or concerns?
Send us an e-mail: [email protected]
Follow @OECtoday on
Created, Designed, and Developed by:
In collaboration with